LIVER CANCER
Clinical trials for LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER trials appear
Sign up with your email to follow new studies for LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental T-Cell therapy for liver cancer shows early promise but trial halted
Disease control TerminatedThis early-stage trial tested a new treatment called ET140203 T cells for adults with advanced liver cancer that had not responded to other therapies. The treatment uses a patient's own immune cells, modified to target cancer cells. The study was stopped early after enrolling onl…
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New combo tackles Drug-Resistant liver cancer in small trial
Disease control TerminatedThis study tested a combination of two drugs (lenvatinib and VIC-1911) in 5 adults with advanced liver cancer that no longer responded to lenvatinib alone. The goal was to see if the combo was safe and could slow cancer growth. The trial was terminated early, so results are limit…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Liver cancer ablation data collection study ends early
Knowledge-focused TerminatedThis study followed over 1,200 people with liver cancer who had a microwave ablation procedure to destroy tumors. Researchers collected information on how well the ablation worked right after the procedure and over time, including tumor recurrence and survival rates. The goal was…
Matched conditions: LIVER CANCER
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 01:00 UTC